Eight Bourbons and a Benzodiazepine: Withdrawal Risk and Physician Coordination
Dewayne is 52, a hotel maintenance supervisor referred by his primary care physician after a routine visit showed AST 96, ALT 110, and platelets 118,000. He drinks 8–10 bourbons nightly and has done so for about 12 years; he has never had treatment. He also takes alprazolam 1 mg three times daily, prescribed by that same PCP for “anxiety and sleep” for four years. Last month he fell in a parking lot and needed seven stitches; he says he “just tripped.” He lives alone, drives himself, and wants to “do this outpatient so I don’t lose my job.” He has no withdrawal symptoms at this moment, his last drink was 10 hours ago, and his blood pressure is 158/94.
1. Determine the level of care using ASAM dimensions, and explain how you would present a recommendation he does not want to hear.
Read the worked answer
Dimensions. D1, withdrawal: high. Daily heavy alcohol plus four years of prescribed alprazolam is a potentially lethal combination; alcohol withdrawal seizures and delirium tremens can appear 12–48 hours after the last drink, and benzodiazepine dependence adds its own withdrawal syndrome. D2, biomedical: moderate to high - abnormal transaminases and low platelets suggest hepatic impairment, which impairs benzodiazepine metabolism and raises sedation and fall risk, consistent with the “trip” in the parking lot. D3, psychiatric: anxiety and insomnia, not imminently dangerous. D4, readiness: low to moderate. D5, relapse potential: high. D6, environment: lives alone, which is a safety concern during withdrawal.
Recommendation: ASAM Level 3.7-WM medically monitored inpatient withdrawal management; Level 4-WM if liver disease proves decompensated or he is medically unstable. Outpatient withdrawal management is not appropriate here.
Presentation: Lead with the reason, not the rule. “I’m not saying this because of your job - I’m saying it because stopping alcohol and Xanax at the same time, alone, at home, is where people seize.” Ask what he fears about absence from work, then point him to his EAP, HR benefits, and legal aid for leave questions rather than giving legal advice yourself. Offer to have the withdrawal program call his employer only with his written consent.
2. How do you coordinate with the PCP about the alprazolam? What do you say, what do you not say, and what consents are required?
Read the worked answer
Consent first. A 42 CFR Part 2-compliant written consent naming the PCP, the purpose (coordination of care for withdrawal management and medication review), and an expiration date. Without it you disclose nothing, including confirmation that he is a patient.
What you convey: your assessment findings - 8–10 drinks nightly for 12 years, the alprazolam dose and duration, the fall, the LFTs and platelets, the current blood pressure - and your clinical concern that alcohol plus a benzodiazepine is a risk combination and that abrupt discontinuation of a four-year benzodiazepine regimen in a dependent patient can itself cause seizures. Ask for the prescriber’s plan and timing so the withdrawal program can dose appropriately.
What you do not do: tell the physician what to prescribe, imply negligence, or suggest the patient “doctor-shopped” when a single prescriber wrote both. The conversation is peer-to-peer and framed as shared risk.
Timing matters. Have this conversation before admission, not after, so the withdrawal management program knows the exact benzodiazepine dose on day one. Document the contact, the information exchanged, and the agreed plan.
3. Draft the post-withdrawal treatment plan: measurable objectives, medication considerations, and the referrals that actually fit his life.
Read the worked answer
Level of care: ASAM Level 2.1 intensive outpatient, three sessions weekly, stepping down to Level 1 - with a written contingency that a return to drinking or a missed week triggers reassessment rather than discharge.
Medication review with the PCP: discuss naltrexone, with caution and monitoring given the elevated transaminases (generally avoid with markedly elevated liver enzymes or acute hepatitis), or acamprosate as an alternative; discuss a supervised benzodiazepine taper rather than abrupt discontinuation; and treat insomnia with CBT-I rather than a substitute sedative. Repeat LFTs and platelets, and monitor blood pressure.
Measurable objectives: complete withdrawal management and attend the first IOP session within 5 days of discharge; 90% attendance over 8 weeks; identify three evening triggers and two replacements for the 7 p.m. bourbon routine; two peer support contacts per week; one follow-up call from you within 72 hours of discharge.
Fit the referrals to his life: he lives alone and drives - build the plan around evening hours and transportation. Add peer support, a primary care follow-up within two weeks, and a check on firearm or medication access in the home if risk emerges. Review at 30 and 90 days with him, and revise rather than restart if he relapses.